Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Clin Exp Immunol1
Search Results
Sort by
- BookPetr Kanovsky, Kailash P. Bhatia, Raymond L. Rosales, editors.Contents:
Part I. Pathophysiology and nosology of dystonia
Dystonia: History of the term and syndrome
Physiology of dystonia
Genetics of dystonia
Nosology and classification of dystonia
Secondary dystonias
Dystonia
parkinsonism syndromes
Dystonia in multiple system atrophy and progressive supranuclear palsy
Psychogenic dystonia
Part II. Treatment of dystonia
Pharmacological treatment of dystonia
Botulinum toxin treatment of dystonia
Long-term BoNT treatment of dystonia
Brain plasticity in dystonia
Surgical treatment of dystonia
Indications of deep brain stimulation in dystonia
Pitfalls of deep brain stimulation in dystonia
Neurorehabilitation in dystonia
Dystonia in Art: The Impact of Psychiatric and Neurological Disease on the Work of the Sculptor F.X. Messerschmidt.Digital Access Springer 2015 - ArticleThatcher N, Swindell R, Crowther D.Clin Exp Immunol. 1979 May;36(2):227-36.Increased lymphocyte cytotoxicity, particularly of 'killer' K cell type was recorded with repeated immunizations of either C. parvum or BCG. A 3 week interval between immunizations was capable of maintaining the increase in cytotoxicity. No marked alterations of 'recall' skin hypersensitivity reactions nor of peripheral blood counts were noted. Expression of cytotoxicity results as percentage 51Cr release, lytic units/ml and cytotoxic capacity (after logit transformation of the cytotoxicity-lymphocyte curves) are described. A 3 week immunization schedule is suggested where BCG and C. parvum are used as immunotherapeutic agents, in the doses quoted.